Atley Pharmaceuticals Inc is a global leader in the development and production of astatine-related pharmaceuticals. Their innovative Atley C100 module is the world's first commercial production module that can purify astatine-211 and synthesize radiopharmaceuticals in an automated process. With a focus on targeted alpha therapy, Atley Solutions offers a curative and less toxic alternative to standard cancer treatments, utilizing alpha emitting radionuclides coupled with cancer-targeting biological molecules. Their expertise spans from drug discovery to drug commercialization, making them the ideal partner for astatine-211 pharmaceutical development projects.
Generated from the website